GSK3878858A
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK3878858A, covering 2025-05-08 to 2025-05-08. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Immunogenicity and Efficacy of GSK S. Aureus Candidate Vaccine (GSK3878858A) When Administered to Healthy Adults (Dose-escalation) and to Adults 18 to 64 Years of Age With a Recent S. Aureus Skin and Soft Tissue Infection (SSTI) [Phase 2]